According to this hypothesis, defects in hepatic insulin clearance promote chronic hyperinsulinaemia, which in turn leads to insulin receptor desensitisation, target tissue insulin resistance and subsequent glucose intolerance. The gene discussed is INS; the disease is Glucose intolerance.